Skip to main content
. 2020 Jul 3;2020:6356459. doi: 10.1155/2020/6356459

Table 5.

Demographic characteristics, neurologic examinations, and electrophysiologic studies for the symptomatic and asymptomatica patients.

Variables Asymptomatic Symptomatic
Patient no. 86 59
Gender (F/M) 33/53 21/38
Age (y) 58.1 ± 7.5 55.9 ± 9.6
BMI (kg/m2) 26.0 ± 3.9 25.6 ± 3.9
Duration of T2DM (y) 5.8 ± 4.8 9.1 ± 5.6∗∗∗
HTN, n (%) 4 (4.7) 3 (5.1)
HbA1C (%) 7.0 ± 1.0 8.1 ± 1.7∗∗∗
T-CHOL (mg/dl) 163 ± 34 176 ± 32
HDL-C (mg/dl) 45 ± 11 48 ± 14
LDL-C (mg/dl) 90 ± 28 96 ± 25
TG (mg/dl) 143 ± 79 141 ± 90
Vit. B12 (pg/ml) 776 ± 677 994 ± 728
Hom (μmol/l) 10 ± 3 10 ± 3
eGFR (ml/min/1.73m2) 101 ± 24 105 ± 29
DPNP, n (%) 0 (0.0) 16 (27.1)∗∗∗

mMNSI, total score 2 ± 1 4 ± 2∗∗∗
 Symptoms of polyneuropathy 0 (0) 59 (100)
 Reduction of ankle reflex 59 (68.6) 57 (96.6)∗∗∗
 Bilateral median neuropathy at wrists 36 (41.9) 38 (64.4)∗∗
 Abnormal thermal test 30 (34.9) 32 (54.2)
 Abnormal vibration 8 (9.3) 22 (37.3)∗∗∗

Abbreviations: mMNSI: modified Michigan Neuropathy Screening Instrument; DSPN: distal symmetrical polyneuropathy; DPNP: diabetic peripheral neuropathic pain; NCS: nerve conduction studies; DN4: Douleur Neuropathique; F: females; M: males; y: years; BMI: body mass index; T2DM: type II diabetes mellitus; HTN: hypertension; HbA1C: glycated haemoglobin; Vit. B12: vitamin B12; HTN: hypertension; Hom: homocysteine; T-CHOL: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglyceride; eGFR: estimated glomerular filtration rate. aSymptomatic DSPN was defined as complaint of symmetrical, bilateral, distal sensory and/or motor defects. Data were presented as n of F/M for gender, n (%) for categorical variables, and mean ± standard deviations (SD) for continuous values by the symptomatic and asymptomatic patients. Data were compared using the chi-squared test for categorical variables and the two-sample t-test for continuous ones. p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.0001 indicate significant difference when comparing the symptomatic and asymptomatic patients.